Both in Pharmaceuticals
IGC Pharma vs TherapeuticsMD
Over the past year IGC returned −49.9% and TXMD returned +55.6%; their daily moves had a correlation of 0.01.
IGC −49.9% TXMD +55.6%Growth of $1, one year, split-adjusted
| Metric | IGC | TXMD |
|---|---|---|
| Price | $0.1950 | $1.82 |
| Market cap | $20.2M | $21.1M |
| Today | +4.84% | +2.25% |
| 1 month | −30.4% | −9.9% |
| 6 months | −38.7% | −10.3% |
| Year to date | −30.7% | +11.7% |
| 1 year | −51.5% | +58.3% |
| Revenue growth (YoY) | −19.2% | −8.7% |
| Gross margin | 18.1% | 100.0% |
| Net margin | −1107.9% | 17.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 6.4× |
| Net cash | -$728.0K | $9.2M |
| Dividend yield | — | — |
| Volatility (60d) | 63.5% | 34.2% |
| Short % of float | 0.7% | 0.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).